BIMO
Data Integrity and Form 483 or Warning Letters
Data integrity is an essential component of both clinical and nonclinical research conducted under the supervision of the Food and Drug Administration.
Data integrity is an essential component of both clinical and nonclinical research conducted under the supervision of the Food and Drug Administration.